Cargando…
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
Oncogenic mutations in KRAS or BRAF are frequent in colorectal cancer and activate the ERK kinase. Here, we find graded ERK phosphorylation correlating with cell differentiation in patient-derived colorectal cancer organoids with and without KRAS mutations. Using reporters, single cell transcriptomi...
Autores principales: | Brandt, Raphael, Sell, Thomas, Lüthen, Mareen, Uhlitz, Florian, Klinger, Bertram, Riemer, Pamela, Giesecke-Thiel, Claudia, Schulze, Silvia, El-Shimy, Ismail Amr, Kunkel, Desiree, Fauler, Beatrix, Mielke, Thorsten, Mages, Norbert, Herrmann, Bernhard G., Sers, Christine, Blüthgen, Nils, Morkel, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606648/ https://www.ncbi.nlm.nih.gov/pubmed/31266962 http://dx.doi.org/10.1038/s41467-019-10954-y |
Ejemplares similares
-
Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
por: Morkel, Markus, et al.
Publicado: (2015) -
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe
por: Gastl, Bastian, et al.
Publicado: (2020) -
Mitogen‐activated protein kinase activity drives cell trajectories in colorectal cancer
por: Uhlitz, Florian, et al.
Publicado: (2021) -
Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS
por: Stelniec-Klotz, Iwona, et al.
Publicado: (2012) -
Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids
por: Riemer, Pamela, et al.
Publicado: (2017)